ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag national cancer institute immunology

3D illustration of a lymphocyte in white and green.
A Quest for the Holy Grail of Cancer Targets
Danielle Gerhard, PhD | Mar 14, 2024 | 5 min read
Christopher Klebanoff hopes that his search for a small fraction of cancer-specific antigens will have a big impact on cancer cell therapies.
3D Rendering of Molecular Interaction in CAR Chimeric Antigen Receptor
Next-generation CAR and TCR Cancer Therapies
Danielle Gerhard, PhD | Mar 15, 2024 | 10+ min read
From smart receptors to novel biologics, scientists plan to overcome the challenges of treating solid tumors.
A bat flying in a dark cave
Turning on the Bat Signal
Hannah Thomasy, PhD | Mar 15, 2024 | 10+ min read
Scientists around the world investigate how bat immune systems cope with viral attacks and how this information could be used to keep humans safe.
An illustration of a small number of virus particles on a blurred background.
A New Piece in the HIV Replication Puzzle
Mariella Bodemeier Loayza Careaga, PhD | Feb 14, 2024 | 4 min read
A host lipid-modifying enzyme plays a key role in HIV envelope formation, viral maturation, and infectivity. 
The Vaginal Microbiome is Finally Getting Recognized
Hannah Thomasy, PhD, Drug Discovery News | Sep 25, 2023 | 10+ min read
Vaginal dysbiosis has long been a taboo subject, but studying and optimizing the vaginal microbiome could be a game changer for women's health.
Cancer Vaccines: A Dose of Prevention
Cancer Vaccines: A Dose of Prevention
The Scientist | Aug 10, 2023 | 1 min read
Discover the latest progress behind therapeutic vaccines that boost the immune system’s cancer-killing abilities.
One Protein to Rule Them All
Shelby Bradford, PhD | Feb 28, 2024 | 10+ min read
p53 is possibly the most important protein for maintaining cellular function. Losing it is synonymous with cancer.
A New mRNA Malaria Vaccine 
Rebecca Roberts, PhD | Nov 30, 2023 | 3 min read
By targeting resident memory T cells in the liver, a novel mRNA malaria vaccine prevented infection, even in those with prior exposure.
<em >The Scientist</em>&rsquo;s Journal Club: Immunology
The Scientist’s Journal Club: Immunology
The Scientist | May 2, 2023 | 1 min read
Scientists present the latest research on the immune response against SARS-CoV-2, the influence of COVID-19 on future vaccine responses, and drivers of T cell development.
Immunology
The Scientist Staff | Jun 23, 1991 | 2 min read
J.J. Goedert, C.M. Kessler, L.M. Aledort, R.J. Biggar, et al., "A prospective study of human immunodeficiency virus type-1 infection and the development of AIDS in subjects with hemophilia," New England Journal of Medicine, 321:1141-48, 1989. James J. Goedert (Viral Epidemiology Section, National Cancer Institute, Bethesda, Md.): "This paper summarizes the substantial contributions of a multidisciplinary team that has worked together for five or more years. The goal of our team has been a bet

Run a Search

ADVERTISEMENT